
The COVID-19 research database enables public health and policy researchers to use real-world data to better understand and combat the COVID-19 pandemic. The database is a pro-bono, cross-industry collaborative, composed of institutions donating technology services, healthcare expertise, and de-identified data. The database is a public-private consortium organized by Datavant, Health Care Cost Institute, Medidata, Mirador Analytics, Veradigm, Change Healthcare, SAS, Snowflake and many others. Please refer to our the partners below for the full list.

Data
The database includes de-identified and limited datasets from medical and pharmacy claims data, EHR data, mortality data, and consumer data.
OVER
85 Billion
Records
VISIBILITY INTO
250M+
People
INCLUDING
5M+
COVID-19 Patients
COVID-19 Research Database Publications
Research is key to mitigating the impacts of COVID-19 across the healthcare system and society. Here is a sampling of the many publications so far about the database:
The Risk of Postoperative Complications After Major Elective Surgery in Active or Resolved COVID-19 in the United States
Impact of telehealth on health care resource utilization during the COVID-19 pandemic
Declines in contraceptive visits in the United States during the COVID-19 pandemic
Evaluation of the Association Between Medicare Eligibility and Excess Deaths During the COVID-19 Pandemic in the US
Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States
The group consists of a representative from all contributing data sources and institutions. This group designed the governance structure for the database, ensuring that data is used in ways consistent with its intent and ensuring the highest level of security and patient protection.

Martin Aboitiz
Founder & CEO, Healthjump

Jamie Blackport
President & Founder, Mirador Analytics

Niall Brennan
Chief Analytics and Privacy Office, Clarify Health Solutions

Arnaub Chatterjee
MHA, MPA, Senior Vice President, Product - Acorn AI, a Medidata company.

Todd Crosslin
Head of Healthcare & Life Sciences, Snowflake

John Danaher
MD, President of Clinical Solutions, Elsevier

Todd Gottula
President, CPO, and Co-Founder, Clarify Health Solutions

Steve Kearney
PharmD, Medical Director, SAS

Jason LaBonte
PhD, Chief Strategy Officer, Datavant

Brian O'Neill
CEO, Office Ally

Patrick J. Sullivan
Senior Vice President, Integrated Analytics, North America Life

Tim Suther
Senior Vice President, Data Solutions, Change Healthcare

Karen Strope
Executive Director of Marketing, Stata

Stuart Green
Senior Vice President & General Manager – Life Sciences, Veradigm
The group consists of industry leaders and This group identifies ways to enhance the database’s impact on COVID-19 research, including identifying opportunities to collaborate with other initiatives.

Marc Berger

Donald M. Berwick

Esther Krofah

Carolyn Magill

David J. Shulkin
MD, Former Secretary of the US Department of Veterans Affairs, MD

Ed Simcox
Chief Strategy Officer at LifeOmic, Former HHS CTO

Lisa Simpson
M.B., B.Ch., M.P.H., FAAP, President and CEO, AcademyHealth

Michael Stebbins
PhD, President of Science Advisors, LLC

Ginger Zielinskie
CEO, Evergreen Strategic Advisors, MBA
The group consists of expert statisticians, ensuring that all data in the database and proposed combinations of data sets are de-identified.

Patrick Baier
PhD, Scheuren Ruffner Consultants

Daniel Barth-Jones
PhD, MPH, Assistant Professor of Clinical Epidemiology, Columbia

John Cook
PHD, Founder, Singular Value Consulting

Andrew Kopelman
J.D., Senior Vice President, Deputy General Counsel & Chief Privacy Counsel, Medidata

Brad Malin
PhD, Professor of Biomedical Informatics, Biostatistics, and Computer Science, Vanderbilt University

Colin Moffatt
PhD, MSc, MRes, Chief Data Scientist, Mirador Analytics
The group ensures that the voice of the patient and the patient experience is captured in proposals and that the database meets high ethical standards.

Donna R. Cryer
J.D., President & CEO of the Global Liver Institute

Deven McGraw
J.D., MPH, Chief Regulatory Officer, Ciitizen

Jan Oldenburg
Principal at Participatory Health Consulting

Andrew C. Wicks
Ruffin Professor of Business Administration, Director, Olsson Center for Applied Ethics
The group reviews all submitted proposals for research to be conducted in the database, ensuring that studies are scientifically rigorous and of the standard to be accepted by peer reviewed publications.

Mark Cullen, Committee Chair
MD, Professor of Medicine at Stanford University Schoool of Medicine.

Julia Adler-Milstein
PhD, Director of the Center for Clinical Informatics & Improvement Research, UCSF

Tom Carton
PhD, MS, LPHI and REACHnet

C. Lee Cohen
MD MBA, a Pulmonary and Critical Care Fellow at Brigham and Women's Hospitals

Sherrine Eid
MPH, Global Lead, Epidemiology and RWE & Global Lead, COVID-19 Epi-response Team, SAS

Aaron Galaznik
MD, RWE Head of Research, Acorn.ai

Mina Hsiang
VP, Policy, Devoted Health

Louise Ivers
MD, Executive Director, Massachusetts General Hospital Center for Global Health

Lee Kallenbach
PhD, MPH, Senior Clinical Consultant, Veradigm

Alan Kaul
PharmD, MBA, FCCP, DAAPM, President Medical Outcomes Management and Co-founder PRACnet

Abel Kho
MD, MS, FACMI, Director of the Institute for Augmented Intelligence in Medicine

Gregory P. Licholai
MD, Chief Medical Information Officer, PRA

Joseph Menzin
PhD, Founder & CEO, BHE

Anna Milewski

Ariel Pakes
PhD, Professor of Economics, Harvard University

Julie Parsonnet
MD, Professor of Medicine and of Health Research & Policy at Stanford

Eric Perakslis
PhD, Rubenstein Fellow, Duke University

Jeremy Racine
Director of Healthcare, Tableau

Sally Rodriguez

James Robins
MD, Professor of Epidemiology & Biostatistics, Harvard T.H. Chan School of Public Health

Charles Safran
MD, MS, FACMI, Professor of Medicine at Harvard Medical School

Misha Segal
MBA, Managing Director, Berkeley Research Group

Robert Shafer

Nan Shao
PhD, Corporate VP, Biostatistics and Statistical Programming at Parexel

PhD, Assistant Professor at the University of Chicago Department of Economics

Lisa Wruck
PhD, MSPH, Director, Center for Predictive Medicine, Duke Clinical Research Institute
The group investigates ways to incorporate omics data and research into the database.

Bruce Church
Chief Math Officer, GNS Healthcare

Ramon Felciano
Chief Technology Officer and VP Strategy & Insights, Qiagen

Dan Shiffman
VP, Data Science, Qiagen

Zach Henderson
Chief Commercial Officer, Glooko

Richard Jenkins
Chief Growth Officer, Aetion

Jason Martin
Corporate Vice President, Global Data Operations, Parexel

Richard Thomas
Strategic Advisory Board, Genstar Capital
How it Works

For Researchers
- Researchers are welcome to register to request access to the COVID-19 Research Database Knowledge Base and the ability to submit research proposals.
- Register with your organizational affiliation. Personal emails will not be accepted.
- Access can be granted only if you intend to conduct non-commercial, non-financial, non-legal-related research.
- Registration requires approval before access is granted. A decision is typically made within 1 business day.
- Once registration is complete, you'll have access to the full knowledge base to learn about the full submission process, the types of datasets accessible, the analytics tools available, and more.
Research Database Principles
- Commercially-sponsored research: Any study paid for, sponsored by, or conducted to serve a sponsor for a commercial application (e.g. feasibility study for a sponsored clinical trial, a health economics and outcome research study to gain favorable reimbursement with payers, outcomes study to show your facility is superior to others in the area, etc.).
- Legal research: Any study to support a legal proceeding (e.g. lawsuit, criminal defense or prosecution, etc.).
- Financial research: Any study to support investing, trading, mergers, acquisitions, divestments, or similar professional or personal finance activities.